Robecosam AG decreased its holdings in shares of Bunge Ltd (NYSE:BG) by 12.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 15,152 shares of the basic materials company’s stock after selling 2,221 shares during the quarter. Robecosam AG’s holdings in Bunge were worth $1,017,000 at the end of the most recent quarter.
A number of other hedge funds have also bought and sold shares of BG. Fuller & Thaler Asset Management Inc. purchased a new position in shares of Bunge during the fourth quarter worth $101,000. Advisor Group Inc. boosted its position in shares of Bunge by 127.8% during the third quarter. Advisor Group Inc. now owns 1,499 shares of the basic materials company’s stock worth $104,000 after buying an additional 841 shares during the period. Cerebellum GP LLC purchased a new position in shares of Bunge during the fourth quarter worth $129,000. American International Group Inc. purchased a new position in shares of Bunge during the fourth quarter worth $197,000. Finally, KCS Wealth Advisory purchased a new position in shares of Bunge during the fourth quarter worth $200,000. 79.37% of the stock is owned by institutional investors.
Several research analysts have recently commented on the company. JPMorgan Chase & Co. upgraded Bunge from a “neutral” rating to an “overweight” rating and set a $90.00 price target for the company in a research report on Wednesday, March 7th. Citigroup upgraded Bunge from a “neutral” rating to a “buy” rating and raised their price target for the stock from $77.99 to $89.00 in a research report on Tuesday, March 6th. Zacks Investment Research upgraded Bunge from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 30th. Credit Suisse Group set a $84.00 price target on Bunge and gave the stock a “buy” rating in a research report on Monday, January 22nd. Finally, Stephens upgraded Bunge from an “equal weight” rating to an “overweight” rating in a research report on Thursday, February 15th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $85.86.
Bunge (NYSE:BG) last released its earnings results on Wednesday, February 14th. The basic materials company reported $0.67 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.48 by ($0.81). The company had revenue of $11.61 billion during the quarter, compared to analysts’ expectations of $12.57 billion. Bunge had a net margin of 0.35% and a return on equity of 4.36%. The company’s revenue for the quarter was down 1.6% on a year-over-year basis. During the same quarter last year, the business posted $1.70 earnings per share. research analysts anticipate that Bunge Ltd will post 3.9 EPS for the current year.
TRADEMARK VIOLATION WARNING: This piece was first published by American Banking News and is the property of of American Banking News. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2018/03/14/bunge-ltd-bg-holdings-cut-by-robecosam-ag.html.
Bunge Limited is an agribusiness and food company with integrated operations that stretch from the farm field to consumer foods. The Company operates through five segments: Agribusiness, Edible Oil Products, Milling Products, Sugar and Bioenergy, and Fertilizer. Its Agribusiness segment is an integrated, global business involved in the purchase, storage, transport, processing and sale of agricultural commodities and commodity products.
Want to see what other hedge funds are holding BG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bunge Ltd (NYSE:BG).
Receive News & Ratings for Bunge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bunge and related companies with MarketBeat.com's FREE daily email newsletter.